« Back to Record
Citation APA

LEVY, A., Hendriks, L., LePéchoux, C., Falk, S., Besse, B., Novello, S., Dingemans, A.-M. C., Hasan, B., Reck, M., Berghmans, T., Faivre-Finn, C., & EORTC 24971/TAX 323 Study Group, (2019). Current management of limited-stage SCLC and CONVERT trial impact: results of the EORTC Lung Cancer Group survey. Lung cancer, 136, 145-147.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/293140

LEVY, A., Hendriks, L., LePéchoux, C., Falk, S., Besse, B., Novello, S., Dingemans, A.-M. C., Hasan, B., Reck, M., Berghmans, T., Faivre-Finn, C., & EORTC 24971/TAX 323 Study Group, (2019). Current management of limited-stage SCLC and CONVERT trial impact: results of the EORTC Lung Cancer Group survey. Lung cancer, 136, 145-147.